About Avenue Therapeutics Inc (ATXI:NSD)
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York. Address: 1140 Avenue of the America, New York, NY, United States, 10036 Read Less
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials ...Read More
Company Website : https://www.avenuetx.com
Address : 1140 Avenue of the America, New York, NY, United States, 10036
Employees : 4
Fiscal Year End : December
Currency:
USD
Country :
USA